Eli Lilly's Antibody Reduces COVID-19 Risk by 80% in Nursing Homes

Cory Renauer, The Motley Fool
·2 min read
Eli Lilly's Antibody Reduces COVID-19 Risk by 80% in Nursing Homes

Results of a clinical trial suggest pre-emptive treatment with bamlanivimab can prevent COVID-19 from spreading through nursing homes.